platelet rich plasma effect on plantar fasciitis
Not Applicable
- Conditions
- plantar fasciitis.Plantar fascial fibromatosis
- Registration Number
- IRCT2014011316201N1
- Lead Sponsor
- Physical Medicine and Rehabilitation ward, Shiraz University of Medical Sciencs
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
patients with unilateral PF or pain prominent in one foot; intractable pain for a minimum of 3 months’ duration ; a VAS score of at least 4 at the insertion of the plantar fascia on calcaneus taking the first step in the morning. Exclusion criteria: usage of NSAIDs within 48 hours of procedure; corticosteroid injection at treatment site within 1 month; having any other associated pathology involving the lower limb; abnormal ESR or CRP level; any systemic disorders.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain. Timepoint: baseline, 3 weeks, 8 weeks. Method of measurement: visual analogue score.;Disability. Timepoint: baseline, 3 weeks and 8 weeks. Method of measurement: persian version of Foot and Ankle Ability Measure(FAAM).
- Secondary Outcome Measures
Name Time Method